120 related articles for article (PubMed ID: 22814462)
41. A comparison of a new oral streptogramin XRP 2868 with quinupristin-dalfopristin against antibiotic-resistant strains of haemophilus influenzae, Staphylococcus aureus, and Streptococcus pneumoniae.
Mabe S; Champney WS
Curr Microbiol; 2005 Dec; 51(6):363-6. PubMed ID: 16252133
[TBL] [Abstract][Full Text] [Related]
42. Comparative antimicrobial activity of gatifloxacin tested against Streptococcus spp. including quality control guidelines and etest method validation. Quality Control Study Group.
Jones RN; Johnson DM; Erwin ME; Beach ML; Biedenbach DJ; Pfaller MA
Diagn Microbiol Infect Dis; 1999 Jun; 34(2):91-8. PubMed ID: 10354857
[TBL] [Abstract][Full Text] [Related]
43. Proposed MIC quality control guidelines for National Committee for Clinical Laboratory Standards susceptibility tests using seven veterinary antimicrobial agents: ceftiofur, enrofloxacin, florfenicol, penicillin G-novobiocin, pirlimycin, premafloxacin, and spectinomycin.
Marshall SA; Jones RN; Wanger A; Washington JA; Doern GV; Leber AL; Haugen TH
J Clin Microbiol; 1996 Aug; 34(8):2027-9. PubMed ID: 8818906
[TBL] [Abstract][Full Text] [Related]
44. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1994)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Kobayashi K; Satou K; Matsumiya H; Saito A; Terai T; Tanno Y; Nishioka K; Arakawa M; Wada K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Matsuda M; Tanimoto H; Nakata K; Nakamori Y; Kusano N
Jpn J Antibiot; 1996 May; 49(5):419-55. PubMed ID: 8752860
[TBL] [Abstract][Full Text] [Related]
45. Development of interpretive criteria and quality control limits for macrolide and clindamycin susceptibility testing of Streptococcus pneumoniae.
Jorgensen JH; Swenson JM; Tenover FC; Barry A; Ferraro MJ; Murray PR; Reller LB
J Clin Microbiol; 1996 Nov; 34(11):2679-84. PubMed ID: 8897164
[TBL] [Abstract][Full Text] [Related]
46. Re-evaluations of disk diffusion quality control ranges for 11 drugs: report from the QC working group of the national committee for clinical laboratory standards.
Jones RN; Cullen S
Int J Antimicrob Agents; 2002 Oct; 20(4):289-92. PubMed ID: 12385686
[TBL] [Abstract][Full Text] [Related]
47. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from patients in primary hospitals in Shanghai from 2007 to 2010].
Zhou CM; Hu BJ; Gao XD; Bao R; Xie HM; Huang SL; Tao LL; He LX
Zhonghua Jie He He Hu Xi Za Zhi; 2013 May; 36(5):346-50. PubMed ID: 24047808
[TBL] [Abstract][Full Text] [Related]
48. Surveillance of susceptibility testing methodologies for Haemophilus influenzae in Canada, including evaluation of disk diffusion test.
Scriver SR; Hoban DJ; McGeer A; Moore TC; Walmsley SL; Low DE
J Clin Microbiol; 1994 Aug; 32(8):2013-5. PubMed ID: 7989560
[TBL] [Abstract][Full Text] [Related]
49. Comparison of BSAC agar dilution and NCCLS broth microdilution MIC methods for in vitro susceptibility testing of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis: the BSAC Respiratory Resistance Surveillance Programme.
Reynolds R; Shackcloth J; Felmingham D; MacGowan A;
J Antimicrob Chemother; 2003 Dec; 52(6):925-30. PubMed ID: 14585864
[TBL] [Abstract][Full Text] [Related]
50. Interpretive criteria and quality control guidelines for lomefloxacin and meropenem in susceptibility tests of Haemophilus influenzae using Haemophilus test medium.
Pfaller MA; Jones RN; Washington JA; Koontz FP; Gerlach EH; Erwin ME
Diagn Microbiol Infect Dis; 1992 Feb; 15(2):145-50. PubMed ID: 1315231
[TBL] [Abstract][Full Text] [Related]
51. Comparative in vitro activity of telithromycin against macrolide-resistant and -susceptible Streptococcus pneumoniae, Moraxella catarrhalis and Haemophilus influenzae.
Walsh F; Carnegy F; Willcock J; Amyes S
J Antimicrob Chemother; 2004 May; 53(5):793-6. PubMed ID: 15056640
[TBL] [Abstract][Full Text] [Related]
52. Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain.
Jorgensen JH; Barry AL; Doern GV; Ferraro MJ; Murray PR
J Clin Microbiol; 1992 Aug; 30(8):2029-32. PubMed ID: 1500510
[TBL] [Abstract][Full Text] [Related]
53. Quality control parameters and interpretive criteria for in vitro susceptibility tests with the macrolide azithromycin. Collaborative Antimicrobial Susceptibility Testing Group.
Barry AL; Thornsberry C; Gavan TL
Eur J Clin Microbiol Infect Dis; 1989 Jun; 8(6):544-9. PubMed ID: 2548865
[TBL] [Abstract][Full Text] [Related]
54. In vitro activity of thiamphenicol against multiresistant Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus in Italy.
Marchese A; Debbia EA; Tonoli E; Gualco L; Schito AM
J Chemother; 2002 Dec; 14(6):554-61. PubMed ID: 12583545
[TBL] [Abstract][Full Text] [Related]
55. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
56. Pharyngeal colonization and drug resistance profiles of Morraxella catarrrhalis, Streptococcus pneumoniae, Staphylococcus aureus, and Haemophilus influenzae among HIV infected children attending ART Clinic of Felegehiwot Referral Hospital, Ethiopia.
Mulu W; Yizengaw E; Alemu M; Mekonnen D; Hailu D; Ketemaw K; Abera B; Kibret M
PLoS One; 2018; 13(5):e0196722. PubMed ID: 29746496
[TBL] [Abstract][Full Text] [Related]
57. Activity of common antibiotics against Branhamella catarrhalis, Haemophilus influenzae, pneumococci, group A streptococci and Staphylococcus aureus in 1983.
Forsgren A; Walder M
Acta Otolaryngol Suppl; 1984; 407():43-9. PubMed ID: 6437134
[TBL] [Abstract][Full Text] [Related]
58. Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.
Bale MJ; Jones RN
J Clin Microbiol; 1993 Sep; 31(9):2538-40. PubMed ID: 8408586
[TBL] [Abstract][Full Text] [Related]
59. Determination of MIC Quality Control Parameters for Exebacase, a Novel Lysin with Antistaphylococcal Activity.
Traczewski MM; Ambler JE; Schuch R
J Clin Microbiol; 2021 Jun; 59(7):e0311720. PubMed ID: 33910968
[TBL] [Abstract][Full Text] [Related]
60.
Flamm RK; Rhomberg PR; Sader HS
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
